3
Total investments
0
Early stage
1
Mid stage
0
Late stage
9y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
May 2018
Arcturus Therapeutics is a global late stage-clinical messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases
Experience · 5 entries
All (5)
Investments (3)
Board (3)
2018
N
NAHS Holding, Inc.
Board Member
Jul 2018
Board Member
May 2018
Arcturus Therapeutics is a global late stage-clinical messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases
2017
N
Board Member
Jun 2017
Our goal at North American Health Care, Inc. is to assist our client-serviced skilled nursing facilities in providing five-star patient services for every person served. As of November 2013, all 35 locations are ranked as five-star facilities by Medicare. Our ratings reflect the organization’s commitment to excellence in patient care, which includes the desire to provide every aging individual serviced a dignified, enjoyable experience.
2005
Executive Officer - Sr. Vice President, Corporate Controller (Principal Accounting Officer)
2005
Allergan is now part of AbbVie.
AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.
For more information about AbbVie, please visit us at www.abbvie.com. Follow @AbbVie on LinkedIn for future updates.
2002
Executive Officer - Vice President, Corporate Controller (Principal Accounting Officer)
2002
Allergan is now part of AbbVie.
AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.
For more information about AbbVie, please visit us at www.abbvie.com. Follow @AbbVie on LinkedIn for future updates.
Investment activity
2017–2018 · 3 investments
Recent (last 2 years)Earlier